Pilot study on the effect of flavonoids on arterial stiffness and oxidative stress in chronic kidney disease

Table 3 Changes in parameters of arterial stiffness at baseline and after treatment with flavonoids

Parameter	Baseline	End of study	P value
PSBP, mmHg	148 ± 16	134 ± 13	< 0.001
PDBP, mmHg	81.00 ± 8.00	76.00 ± 6.32	0.051
cfPWV, m/s	8.85 (6.7, 11.8)	8.20 (5.1, 9.2)	< 0.001
CSBP, mmHg	156 ± 23	137 ± 16	0.004
CDBP, mmHg	90 ± 14	80 ± 10	0.002
CPP, mmHg	59 (44, 69)	48 (37, 60)	0.003
CHR, pulse/min	69 ± 14	66 ± 9	0.370
AIx, %	26.5 ± 10.0	32.5 ± 13.3	0.510
Ap	17.44 (9.50, 21.00)	14.25 (9.50, 18.75)	0.780

AIx: Augmentation index; Ap: Augmentation pressure; CDBP: Central diastolic blood pressure; cfPWV: Carotid-femoral pulse wave velocity; CHR: Central heart rate; CPP: Central pulse pressure; CSBP: Central systolic blood pressure; PDBP: Peripheral diastolic blood pressure; PSBP: Peripheral systolic blood pressure.